{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T22:54:19Z","timestamp":1774479259826,"version":"3.50.1"},"reference-count":46,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,3,12]],"date-time":"2012-03-12T00:00:00Z","timestamp":1331510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asia-Pac J Clncl Oncology"],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aim:\u2003<\/jats:bold> Carcinosarcoma of the fallopian tube is extremely rare and the therapeutic prognosis of this disease is unknown.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold> We report on four new cases of this disease and have reviewed 59 carcinosarcomas of the fallopian tube and analyzed the prognosis with respect to the chosen therapeutic method in order to explore the most appropriate therapy.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> Out of the 59 patients reviewed, the prognosis was examined in 51 patients that allowed it to be tracked. The 3\u2010year survival rates were 63% for the 27 stage I\/II patients and 40% for the 24 stage III\/IV patients. The 3\u2010year survival rates were 36% for the 14 surgery\u2010alone patients, 59% for the 13 radiation therapy following surgery patients, 54% for the 27 chemotherapy following surgery patients (the chemotherapy group) and 100% in for the four chemoradiotherapy following surgery patients. A significant difference was observed between the surgery\u2010alone and the chemotherapy groups (Wilcoxon test, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05), the chemoradiotherapy group demonstrating a better tendency as to survival rate than the surgery\u2010alone group (Wilcoxon test, <jats:italic>P<\/jats:italic>\u2003=\u20030.06). Stage III\/IV patients accounted for a two\u2010thirds of the chemotherapy group. The 3\u2010year survival rate for all the stage I\u2013IV patients was 63% when a platinum drug was used and 21% when it was not used, suggesting the possibility of extending life through the use of a platinum drug.<\/jats:p><jats:p><jats:bold>Conclusion:\u2003<\/jats:bold> Chemotherapy using a platinum drug after surgery seems to be most effective treatment in this disease.<\/jats:p>","DOI":"10.1111\/j.1743-7563.2011.01513.x","type":"journal-article","created":{"date-parts":[[2012,3,12]],"date-time":"2012-03-12T19:13:43Z","timestamp":1331579623000},"page":"303-311","source":"Crossref","is-referenced-by-count":21,"title":["Carcinosarcoma of the fallopian tube: Report of four cases and review of literature"],"prefix":"10.1111","volume":"8","author":[{"given":"Yoshihito","family":"YOKOYAMA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"YOKOTA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"FUTAGAMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"MIZUNUMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,3,12]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(80)90050-5"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(77)90021-X"},{"key":"e_1_2_5_4_2","first-page":"554","article-title":"Malignant mixed M\u00fcllerian tumor of the fallopian tube: report of a case","volume":"36","author":"DeQuerioz AC","year":"1970","journal-title":"Obstet Gynecol"},{"key":"e_1_2_5_5_2","first-page":"707","article-title":"Malignant mixed M\u00fcllerian tumor of the uterine tube","volume":"41","author":"Wu JP","year":"1973","journal-title":"Obstet Gynecol"},{"key":"e_1_2_5_6_2","first-page":"84","article-title":"Mixed M\u00fcllerian tumors of the oviduct","volume":"44","author":"Acosta AA","year":"1974","journal-title":"Obstet Gynecol"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197610)38:4<1687::AID-CNCR2820380441>3.0.CO;2-H"},{"key":"e_1_2_5_8_2","first-page":"43","article-title":"Mixed mesodermal tumor of the fallopian tube: report of a case and review of literature","volume":"26","author":"Jain U","year":"1977","journal-title":"Md State Med J"},{"key":"e_1_2_5_9_2","first-page":"1431","article-title":"Malignant mixed M\u00fcllerian tumors","volume":"78","author":"Oka M","year":"1978","journal-title":"N Y State J Med"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1980.tb04591.x"},{"key":"e_1_2_5_11_2","first-page":"207","article-title":"Mixed mesodermal tumor of the fallopian tube: a case report","volume":"70","author":"Holst N","year":"1981","journal-title":"Ann Chir Gynaecol"},{"key":"e_1_2_5_12_2","first-page":"749","article-title":"Heterologous carcinosarcoma of the fallopian tube: a case report","volume":"27","author":"O'Toole RV","year":"1982","journal-title":"J Reprod Med"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(83)90020-3"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19841015)54:8<1517::AID-CNCR2820540807>3.0.CO;2-V"},{"key":"e_1_2_5_15_2","first-page":"386","article-title":"Malignant mixed M\u00fcllerian tumor of the fallopian tube","volume":"111","author":"Buchino JJ","year":"1987","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_5_16_2","first-page":"75","article-title":"Malignant mixed M\u00fcllerian tumor of the fallopian tube: a case report","volume":"42","author":"Chen CJ","year":"1988","journal-title":"Chin Med J (Taipei)"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(89)90635-5"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(89)90650-1"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(89)90119-4"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(90)90352-L"},{"key":"e_1_2_5_21_2","first-page":"272","article-title":"Malignant mixed M\u00fcllerian tumor of fallopian tube: report of a case and review of literature","volume":"45","author":"Liang WW","year":"1990","journal-title":"Chin Med J (Taipei)"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1990.tb01120.x"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(92)90086-X"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1993.1199"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930101)71:1<187::AID-CNCR2820710129>3.0.CO;2-C"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01370932"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016349409015779"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2004.00166.x"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1048-891X.2004.14432.x"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1080\/01443610400018825"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.11.053"},{"key":"e_1_2_5_32_2","first-page":"354","article-title":"Malignant mixed M\u00fcllerian tumor of the fallopian tube of heterologous variety \u2013 a case report","volume":"48","author":"Das TK","year":"2005","journal-title":"Indian J Pathol Microbiol"},{"key":"e_1_2_5_33_2","first-page":"509","article-title":"Malignant mixed M\u00fcllerian tumor with heterologous component arising in the fallopian tube \u2013 a case report","volume":"27","author":"Hudelist G","year":"2006","journal-title":"Eur J Gynaecol Oncol"},{"key":"e_1_2_5_34_2","first-page":"511","article-title":"Malignant mixed M\u00fcllerian tumor of fallopian tube coincident with a primary serous carcinoma of the ovary","volume":"28","author":"Nappi L","year":"2007","journal-title":"Eur J Gynaecol Oncol"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-008-0767-1"},{"key":"e_1_2_5_36_2","first-page":"538","article-title":"Fallopian tube malignant mixed M\u00fcllerian tumor (carcinosarcoma): a case report with immunohistochemical profiling","volume":"29","author":"Kourea HP","year":"2008","journal-title":"Eur J Gynaecol Oncol"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1080\/01443610902780815"},{"key":"e_1_2_5_38_2","first-page":"126","article-title":"Primary malignant mixed M\u00fcllerian tumour of the fallopian tube. Report of a case","volume":"31","author":"Skafida E","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.09.027"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.6001"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2001.6256"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.05.048"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2007.11.029"},{"key":"e_1_2_5_44_2","first-page":"5379","article-title":"Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors","volume":"57","author":"Wada H","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_5_45_2","first-page":"114","article-title":"Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity","volume":"60","author":"Fujii H","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_5_46_2","first-page":"619","article-title":"p53 gene mutation in female genital tract carcinosarcomas (malignant mixed M\u00fcllerian tumors): a clinicopathologic study of 74 cases","volume":"7","author":"Costa MJ","year":"1994","journal-title":"Mod Pathol"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.12.006"}],"container-title":["Asia-Pacific Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1743-7563.2011.01513.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1743-7563.2011.01513.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T12:52:10Z","timestamp":1697374330000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1743-7563.2011.01513.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,12]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.1111\/j.1743-7563.2011.01513.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1743-7563.2011.01513.x","archive":["Portico"],"relation":{},"ISSN":["1743-7555","1743-7563"],"issn-type":[{"value":"1743-7555","type":"print"},{"value":"1743-7563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,12]]}}}